A research paper published in the Journal of Parkinson's Disease in April 2016 discussed a clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells for transplantation into PD patients.

The published article discussed stem cell breakthroughs for the treatment of PD in recent years which have shown that it is possible to make dopamine cells from embryonic stem cells and transplant them to positive effect into the brain of animal models, replacing cells lost to the disease. Human embryonic stem cells have been manipulated in the laboratory to produce a new generation of dopamine cells that behave like native dopamine cells when transplanted.

Read more about this interesting area of research...